Clinical Trial Detail

NCT ID NCT01937715
Title A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Pfizer
Indications

colorectal cancer

Therapies

Bevacizumab

Gedatolisib

FOLFIRI

Age Groups: adult

Additional content available in CKB BOOST